Rev Esp Quimioter 2022;35(Suppl.3):2-5
Vulnerability to SARS-CoV-2 infection and disease: ripping the curl after the storm
PABLO BARREIRO, JESÚS SAN ROMÁN
Published: 24 October 2022
SARS-CoV-2 infection now seems to have entered the announced endemic phase. The population’s immunity is increasingly more robust, thanks to successive vaccination and booster campaigns, and the almost inevitable exposure and re-exposure to the virus itself, which has truly served as a natural immunizing mechanism. On the other hand, the genetic drift of the virus is leading it to become another catarrhal agent, as are the other endemic human coronaviruses. However, it should not be lost sight of that there are still segments of the population with susceptibility to severe COVID, who will be candidates to continue receiving vaccine boosters or antiviral drugs in the initial stages of infection.
Rev Esp Quimioter 2022; 35(Suppl.3):2-5 [Full-text PDF]